» Skip to Content

HOME > Cancer Web 2.0 > Translational Research > Patient Derived Tumor

Patient Derived Tumor

IRCR's TRO is a preclinical Translational Research Organization (TRO) providing specialty pharmacology services in cancer.

Patient Derived Tumor
Cancer Type Image Total Primary Cell(P) Tissue Blood Animal Injection In vivo tumor formation In vivo passage
P0 P1 P2 MA/
WE
PFH FH B BP P0 P1
Glioblastoma 45 36 18 0 37 37 37 33 37 21 ongoing
Brain Metastases 19 10 3 1 11 10 10 16 17 19 ongoing 4 0
Colorectal cancer 88 51 5 0 88 87 87 88 88 88 36/88 7 2
Colorectal Metastases 20 13 1 0 20 19 19 19 19 19 12/20 4 4
Colon normal tissue 105 0 0 0 104 105 105 0 0 0 0 0
Pancreas 23 9 0 0 8 8 8 8 8 23 4/23 2 2
Pancreas normal tissue 1 0 0 0 1 1 1 0 0 0 0 0
Breast 41 0 0 0 0 0 0 0 0 41 1 1
Gall bladder 1 0 0 0 1 1 1 1 1 1 0 0
Gall bladder normal tissue 1 0 0 0 1 1 1 1 1 0 0 0
Bladder 3 3 0 0 3 3 3 2 2 3 0 0